Skip to main content
logo
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
29.46
-0.18 (-0.61%)
At close: Jun 5, 2026, 4:00 PM EDT
29.35
-0.11 (-0.37%)
After-hours: Jun 5, 2026, 6:49 PM EDT

Cue Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
32.7327.479.295.491.2514.94
Revenue Growth (YoY)
309.60%195.75%69.16%340.96%-91.67%373.68%
Gross Profit
32.7327.479.295.491.2514.94
Selling, General & Admin
16.2216.2414.5916.6816.1717.31
Research & Development
36.0937.7436.340.838.5841.35
Other Operating Expenses
0.020.03-0.090.16-0.28-
Total Operating Expenses
52.3454.0250.7957.6454.4758.65
Operating Income
-19.61-26.55-41.5-52.15-53.23-43.71
Interest Income
0.760.811.622.660.930.05
Interest Expense
-0.18-0.36-0.8-1.25-0.71-
Total Non-Operating Income (Expense)
0.580.450.831.420.220.05
Pretax Income
2.09-26.1-40.67-50.73-53.01-43.67
Provision for Income Taxes
0.50.5---0.5
Net Income
-19.52-26.6-40.67-50.73-53.01-44.16
Net Income to Common
-19.52-26.6-40.67-50.73-53.01-44.16
Shares Outstanding (Basic)
432211
Shares Outstanding (Diluted)
432211
Shares Change (YoY)
80.50%68.18%23.11%28.35%13.95%9.05%
EPS (Basic)
-5.58-8.40-21.60-33.30-44.70-42.30
EPS (Diluted)
-5.58-8.40-21.60-33.30-44.70-42.30
Shares Outstanding
3.263.222.061.571.431.07
Free Cash Flow
-24.61-21.86-36.4-39.96-41.98-39.75
Free Cash Flow Per Share
-6.55-6.92-19.38-26.20-35.33-38.12
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-59.90%-96.67%-446.86%-949.89%-4275.10%-292.56%
Profit Margin
4.84%-96.85%-437.97%-924.10%-4257.83%-295.56%
FCF Margin
-75.17%-79.60%-391.89%-727.89%-3371.65%-266.04%
EBITDA
-18.18-25.59-41.1-51.59-52.3-42.45
EBITDA Margin
-55.55%-93.18%-442.59%-939.76%-4201.04%-284.14%
EBIT
-19.61-26.55-41.5-52.15-53.23-43.71
EBIT Margin
-59.90%-96.67%-446.86%-949.89%-4275.10%-292.56%
Effective Tax Rate
23.98%-1.92%0.00%0.00%0.00%-1.13%
SEC Filings: 10-K · 10-Q